Mucopolysaccharidoses: Anesthetic considerations and clinical manifestations

Middle East Journal of Anesthesiology

Volumn 21, Issue 2, 2011, Pages 243-253

  Sam, Jermale A ^a   Baluch, Amir R ^b   Niaz, Rashid S ^c   Lonadier, Lindsey ^c   Kaye, Alan D ^d  

^a RIVERSIDE METHODIST HOSPITAL   (United States)

^b Louisiana State University Health Science Center ^*

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHESIA; CLASSIFICATION; HUMAN; METHODOLOGY; MUCOPOLYSACCHARIDOSIS; REVIEW;

ANESTHESIA; HUMANS; MUCOPOLYSACCHARIDOSES;

EID: 84857269430     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. WALKER RW, DAROWSKI M, MORRIS P, WRAITH JE Anaesthesia and mucopolysaccharidoses. A review of airway problems in children. Anaesthesia; 1994, 49:1078-84.
2. BAINES D, KENEALLY J: Anaesthetic implications of the mucopolysaccharidoses: a fifteen year experience in a children's hospital. Anaesth Intensive Care; 1983, 11:198-202.
3. HERRICK IA, RHINE EJ: The mucopolysaccharidoses and anaesthesia: a report of clinical experience. Can J of Anaesth; 1988, 35:67-73.
4. NEUFELD EF, MUENZER J, ET AL: The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W, et al., editors. The metabolic and molecular bases of inherited disease. 8. New York: McGraw-Hill; 2001, pp. 3421-3452.
5. WAPPNER RS: Lysosomal Storage Disorders. In: McMillan JA, Feigin RD, et al., editors. Oski's Pediatrics Principles and practice. 4. Pennsylvania: JB Lippincott Co, 2006, pp. 2199-2217.
6. SJORGREN P, PEDERSEN T, STEINMETZ H: Mucopolysaccharidoses and anesthetic risks. Acta Anaesthesiol Scand; 1987, 31:214-218.
7. WRAITH JE: The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child; 1995, 72:263-267.
8. MUENZER J: Mucopolysaccharidoses. Adv Pediatr; 1986, 33:269-302.
9. SEMENZA GL, PYERITZ RE: Respiratory complications of mucopolysaccharide storage disorders. Medicine (Baltimore); 1988, 67:209-219.
10. BELANI KG, KRIVIT W, CARPENTER BL, ET AL: Children with mucopolysaccharidoses: perioperative care, morbidity, mortality, and new findings. J Pediatr Surg; 1993, 28:403-408.
11. KEMPTHORNE PM, BROWN TC: Anaesthesia and the mucopolysaccharidoses: a survey of techniques and problems. Anaesth Intensive Care; 1983, 11:203-207.
12. MOORES C, ROGERS JG, MCKENZIE IM, ET AL: Anaesthesia for children with mucopolysaccharidoses. Anaesth Intensive Care; 1996, 24:459-463.
13. DIAZ JH, BELANI KG: Perioperative Management of children with mucopolysaccharidoses. Anesth Analg; 1993, 77:1261-70.
14. Wraith JE: The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother; 2005, 6(3):489-506.
15. KING DH, JONES RM, BARNETT MB: Anaesthetic considerations in the mucopolysaccharidoses. Anesthesia; 1984, 39:126-31.
16. MUENZER J, WRAITH JE, CLARKE LA: International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: Management and treatment guidelines. Pediatrics; 2009, 123:19-29.
17. WALKER RW, COLOVIC V, ROBINSON DN, ET AL: Case Report: Postobstructive pulmonary oedema during anaesthesia in children with mucopolysaccharidoes. Paediatr Anaesth; 2003, 13:441-447.
18. LINSTEDT U, MAIER C, JOEHNK H, ET AL: Threatening spinal cord compression during anesthesia in a child with mucopolysaccharidosis VI. Anesthesiology; 1994, 80:227-229.
19. BUTLER MG, HAYES BG, HATHAWAY MM, ET AL: Specific Genetic Diseases at Risk for Sedation/Anesthesia complications. Anesth Analg; 2000, 91:837-55.
20. SJORGEN P, PEDERSEN T: Anaesthetic problems in Hurler-Scheie syndrome. Report of two cases. Acta Anaesthesiol Scand; 1986, 30:484-6.
21. MUENZER J: The mucopolysaccharidoses: A heterogeneous group of disorders with variable pediatric presentations. J Pediatr; May 2004, 144:S27-34.
22. VELLODI A, YOUNG EP, COOPER A, Et Al: Bone marrow transplantation for mucopolysaccharidosis type I: Experience of two British centres. Arch Dis Child; 1997, 76:92-99.
23. VIJAY S, WRAITH JE: Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I. Acta Paediatr; 2005, 94(7):872-877.
24. WENGER DA, COPPOLA S, LIU SL: Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol; 2003, 60(3):322-328.
25. MEIKLE PJ, HOPWOOD JJ, CLAGUE AE, CAREY WF: Prevalence of lysosomal storage disorders. JAMA; 1999, 281(3):249-254.
26. STEVENS JM, KENDALL BE, CROCKARD HA, RANSFORD, A: The odontoid process in Morquio-Brailsford's disease. The effects of occipitocervical fusion. J Bone Joint Surg Br; 1991, 73:851.
27. TANDON V, WILLIAMSON JB, COWIE RA, WRAITH JE: Spinal problems in mucopolysaccharidosis I (Hurler syndrome). J Bone Joint Surg Br; 1996, 78:938.
28. JONES KL: Storage disorders. In: Smith's Recognizable Patterns of Human Malformation. 6. Philadelphia, Pa: WB Saunders Co, 2005, 452-471.
29. ASHWORTH JL, BISWAS S, WRAITH E, LLOYD CI: Mucopolysaccharidoses and the Eye. Survey of ophthalmology; Jan 2006, 51(1):1-17.
30. KOTTLER U, DEMIR D, SCHMIDTMANN I, BECK M, PITZ S: Central Corneal Thickness in Mucopolysaccharidosis II and VI. Cornea. Mar; 2010, 29(3):260-2.
31. HAYES E, BABIN R, PLATZ C: The otologic manifestations of mucopolysaccharidoses. Am J Otol; 1980, 2:65-69.
32. RUCKENSTEIN MJ, MACDONALD RE, ET AL: The management of otolaryngological problems in the mucopolysaccharidoses: a retrospective review. J Otolaryngol; 1991, Jun, 20(3):177-83.
33. BECK M: Mucopolysaccharidosis Type II (Hunter Syndrome): Clinical Picture and Treatment. Curr Pharm Biotechnol; 2011, in press.
34. DE RUIJTER J, VALSTAR MJ, WIJBURG FA: Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Emerging Treatment Strategies. Curr Pharm Biotechnol; 2011, in press.